Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metabolic Dysfunction-Associated Steatohepatitis”

230 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 230 results

Testing effectiveness (Phase 2)Looking for participantsNCT07145151
What this trial is testing

UBT251 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Who this might be right for
Metabolic Dysfunction-associated Steatohepatitis (MASH)
The United Bio-Technology (Hengqin) Co., Ltd. 156
Early research (Phase 1)Study completedNCT05395481
What this trial is testing

A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH)Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)
Eli Lilly and Company 115
Not applicableUnknownNCT06304844
What this trial is testing

Risk of CKD in Diabetic Patients With MAFLD

Who this might be right for
Type 2 Diabetes
Sohag University 300
Not applicableLooking for participantsNCT06768216
What this trial is testing

Effect of Indianized Version of Mediterranean Diet vs. Low Fat Diet on Hepatic Steatosis in Overweight Children and Adolescent With MASLD

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease
Institute of Liver and Biliary Sciences, India 134
Not applicableUnknownNCT05913986
What this trial is testing

Supplementation With Alpha-lipoic Acid and Silybum Marianum(LUDLEV®) for the Improvement of Fatty Liver Disease

Who this might be right for
Metabolic Associated Fatty Liver Disease
Saluz Investigación S. C. 50
Early research (Phase 1)Not Yet RecruitingNCT07830758
What this trial is testing

Resmetirom in Patients With MASH and HFpEF

Who this might be right for
MASH - Metabolic Dysfunction-Associated SteatohepatitisHeart Failure With Preserved Ejection Fraction (HFPEF)
Madrigal Pharmaceuticals, Inc. 90
Not applicableNot Yet RecruitingNCT07285135
What this trial is testing

Dietary Glycine Supplementation in Metabolic Dysfunction-associated Steatotic Liver Disease

Who this might be right for
Metabolic Dysfunction Associated Fatty Liver Disease
Singapore General Hospital 60
Not applicableNot Yet RecruitingNCT07793279
What this trial is testing

Hypothyroidism and Liver Fibrosis Severity in MASLD

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseHypothyroidismLiver Cirrhosis+1 more
Assiut University 85
Early research (Phase 1)Study completedNCT07331545
What this trial is testing

Safety, Tolerability, PK, PD, and Immunogenicity of QL2401 in Healthy Chinese Adults

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis(MASH)
Qilu Pharmaceutical Co., Ltd. 71
Not applicableLooking for participantsNCT07070362
What this trial is testing

Digital Early Warning System for Acute Lung Injury in Liver Surgery

Who this might be right for
Acute Lung Injury(ALI)Liver CirrhosisARDS, Human+4 more
Beijing Tsinghua Chang Gung Hospital 3,000
Post-approval studies (Phase 4)Not Yet RecruitingNCT07663643
What this trial is testing

Fuzheng Huayu Tablets for Metabolic Dysfunction-Associated Fatty Liver Cirrhosis (Compensated): A Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Study

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver Cirrhosis
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 459
Not applicableNot Yet RecruitingNCT07777198
What this trial is testing

Liver Stiffness Changes by iLivTouch to Predict Liver-Related Events in MAFLD

Who this might be right for
MAFLD
Beijing Friendship Hospital 2,303
Not applicableNot Yet RecruitingNCT06907563
What this trial is testing

Long-term Follow-up to Determine Outcome in Liver Disease (LOVE Study)

Who this might be right for
Steatotic Liver DiseaseMASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)Steatotic Liver Disease of Mixed Origin (MetALD)+1 more
Universität des Saarlandes 30,000
Testing effectiveness (Phase 2)Looking for participantsNCT06588699
What this trial is testing

Digoxin In NASH (CODIN)

Who this might be right for
NASHNAFLDMASH - Metabolic Dysfunction-Associated Steatohepatitis+5 more
Yale University 144
Testing effectiveness (Phase 2)Looking for participantsNCT07459504
What this trial is testing

SMART Diets for MASLD

Who this might be right for
Metabolic-dysfunction Associated Steatotic Liver Disease
Michigan State University 102
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07276204
What this trial is testing

Betaine vs. Placebo for Serologically Diagnosed Metabolic Dysfunction-associated Steatohepatitis (MASH)

Who this might be right for
MASH - Metabolic Dysfunction-Associated Steatohepatitis
Southern California Institute for Research and Education 70
Testing effectiveness (Phase 2)Study completedNCT04555434
What this trial is testing

Effects of Probiotics (P. Pentosaceus, L. Lactis or L. Helveticus) in NASH

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseMASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
Chuncheon Sacred Heart Hospital 89
Testing effectiveness (Phase 2)Study completedNCT06482112
What this trial is testing

Alternate Dosing Study of MK-6024 in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (MK-6024-016)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseNon-alcoholic Fatty Liver DiseaseNonalcoholic Fatty Liver Disease+1 more
Merck Sharp & Dohme LLC 124
Not applicableLooking for participantsNCT07083336
What this trial is testing

Liver Fat as a Dietary Target of the Chinese Medical Nutrition Therapy (CMNT) Diet for Treating Type 2 Diabetes With Nonalcoholic Fatty Liver Disease (Version 3.0)

Who this might be right for
Type 2 Diabetes MellitusMetabolic Dysfunction-associated Steatotic Liver Disease
State Key Laboratory of Subhealth Intervention Technology 120
Post-approval studies (Phase 4)Enrolling By InvitationNCT06845345
What this trial is testing

Effect of an Early Time Restricted Eating Mediterranean Diet Compared to Naltrexone/Bupropion on Liver Fibrosis in People With Cardiometabolic Risk Factors in a Hospital Outpatient Clinic (MEDFAST-study)

Who this might be right for
Diabetes Mellitus, Type 2Liver FibrosisLiver Steatoses+9 more
Carmen Dietvorst 70
Next Page